Skip to main content
Clinical Trials/ACTRN12616000281493
ACTRN12616000281493
Completed
Not Applicable

The use of simultaneous EEG and fMRI to monitor the effects of ketamine and midazolam on brain activity in healthy adult males

The University of Auckland0 sites30 target enrollmentMarch 3, 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Healthy volunteers: Anaesthetic sedation
Sponsor
The University of Auckland
Enrollment
30
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 3, 2016
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
Male

Investigators

Eligibility Criteria

Inclusion Criteria

  • \*Participant is willing and able to give informed consent for participation in the study
  • \*In the Investigators’ opinion, is able and willing to comply with all study requirements

Exclusion Criteria

  • \*Cardiovascular conditions including abnormal heart rate and blood pressure checked at screening.
  • \*Participants who have participated in another research study involving an investigational product in the past 12 weeks.
  • \*History of psychosis or personality disorder.
  • \*Any unstable medical or neurologic condition.
  • \*Substance abuse or dependence in previous 6 months.
  • \*Any history of abuse of ketamine or benzodiazepenes.
  • \*Contraindication to the use of ketamine/midazolam according to manufacturer guidelines.
  • \*Body\-weight \<50kg or \>120kg.
  • \*BMI \<18\.5 or \> 30
  • \* Failure of the Health Questionnaire section of the Anaesthesia assessment patient questionnaire”.

Outcomes

Primary Outcomes

Not specified

Similar Trials